Alpha 2.0
Login Register
» Articles » PMID: 24702994

Identifiability and Privacy in Pluripotent Stem Cell Research

Overview
Journal Cell Stem Cell
Publisher Cell Press
Specialty Cell Biology
Date 2014 Apr 8
PMID 24702994
Citations 19
Authors
Rosario Isasi
Peter W Andrews
Jay M Baltz
Annelien L Bredenoord
Paul Burton
Ing-Ming Chiu
Sara Chandros Hull
Ji-Won Jung
Andreas Kurtz
Geoffrey Lomax
Tenneille Ludwig
Michael McDonald
Clive Morris
Huck Hui Ng
Heather Rooke
Alka Sharma
Glyn N Stacey
Clare Williams
Fanyi Zeng
Bartha Maria Knoppers
Affiliations
Soon will be listed here.
Abstract

Data sharing is an essential element of research; however, recent scientific and social developments have challenged conventional methods for protecting privacy. Here we provide guidance for determining data sharing thresholds for human pluripotent stem cell research aimed at a wide range of stakeholders, including research consortia, biorepositories, policy-makers, and funders.

Citing Articles

Guidelines for managing and using the digital phenotypes of pluripotent stem cell lines.

Wells C, Guhr A, Bairoch A, Chen Y, Hu M, Loser P Stem Cell Reports. 2024; 19(10):1369-1378.

PMID: 39332404 PMC: 11561460. DOI: 10.1016/j.stemcr.2024.08.009.

Facilitating the ethical sourcing of donor hematopoietic stem cells for cell and gene therapy research and development.

Hamad L, Chekar C, Anthias C, Machin L Regen Med. 2024; 19(6):317-326.

PMID: 38889086 PMC: 11346549. DOI: 10.1080/17460751.2024.2357930.

Developing Policy for the Healthy Life Trajectories Initiative: Going from National to International.

Patrinos D, Kleiderman E, Fraser W, Zawati M Biopreserv Biobank. 2023; 21(3):267-274.

PMID: 37192471 PMC: 10282825. DOI: 10.1089/bio.2022.0198.

Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical Applications.

Abberton K, McDonald T, Diviney M, Holdsworth R, Leslie S, Delatycki M Stem Cells Transl Med. 2022; 11(10):1052-1060.

PMID: 36073721 PMC: 9585951. DOI: 10.1093/stcltm/szac060.

Manufacturing with pluripotent stem cells (PSConf 2021): Key issues for future research and development.

Stacey G, Cao J, Hu B, Zhou Q Cell Prolif. 2022; 55(8):e13301.

PMID: 35933704 PMC: 9357356. DOI: 10.1111/cpr.13301.

References
1.
Knoppers B . Consent to 'personal' genomics and privacy. Direct-to-consumer genetic tests and population genome research challenge traditional notions of privacy and consent. EMBO Rep. 2010; 11(6):416-9. PMC: 2892328. DOI: 10.1038/embor.2010.69. View
2.
McKernan R, Watt F . What is the point of large-scale collections of human induced pluripotent stem cells?. Nat Biotechnol. 2013; 31(10):875-7. PMC: 3825502. DOI: 10.1038/nbt.2710. View
3.
Stacey G, Crook J, Hei D, Ludwig T . Banking human induced pluripotent stem cells: lessons learned from embryonic stem cells?. Cell Stem Cell. 2013; 13(4):385-8. DOI: 10.1016/j.stem.2013.09.007. View
4.
Kreiner T, Irion S . Whole-genome analysis, stem cell research, and the future of biobanks. Cell Stem Cell. 2013; 12(5):513-6. DOI: 10.1016/j.stem.2013.04.024. View
5.
Gymrek M, McGuire A, Golan D, Halperin E, Erlich Y . Identifying personal genomes by surname inference. Science. 2013; 339(6117):321-4. DOI: 10.1126/science.1229566. View